Arboretum Ventures
Kirk Malloy, PhD is the founder and principal at BioAdvisors, LLC, where he provides strategic consulting services to life science, diagnostics, and genomics companies. Prior to founding BioAdvisors, Kirk held executive leadership roles at Illumina, Inc. from 2002 to 2016, most recently as Senior Vice President and General Manager of Life Sciences and Applied Markets. Before Illumina, he held various commercial leadership positions at Biosite Diagnostics and QIAGEN Inc. Kirk serves as a board member and advisor for several life science companies, including Nanostring Technologies (Nasdaq: NSTG), Jumpcode Genomics, Tagomics, Phoseon Technology, and Verogen, where he served as the company’s founding CEO. Kirk earned his B.S. in Biology from the University of Miami, and his MS and PhD from the University of Delaware and held post-doctoral and instructor positions at Boston University and Northeastern University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Arboretum Ventures
Arboretum Ventures is a venture capital firm specializing in the healthcare sector. Headquartered in Ann Arbor, Arboretum invests throughout the United States, but with a preference for Midwest opportunities. Their team targets capital efficient companies that can meaningfully reduce healthcare costs in their areas of expertise: devices, diagnostics, services, and IT.